Related posts

Most Anticipated Earnings: IAG-T, BDT-T and more Canadian Companies Reporting Earnings this Week (Nov 04-08)Weekly 52-Week Low (or 52-Week High): BDT-T, BN-T, YES-X, SPB-T and More 52-Week Highs and Lows (Oct 09-15)Most Anticipated Earnings: MRE-T, PSI-T and more Canadian Companies Reporting Earnings this Week (Aug 05-09).
Investor Insights

This summary was created by AI, based on 5 opinions in the last 12 months.

VitalHub Corp. has received positive reviews from experts, highlighting the company's strong profitability metrics, potential for multi-compound growth, savvy management, and successful execution of acquisitions. The recent acquisition of Strata Health, funded through a combination of cash and shares, has been regarded as highly accretive and efficient for VHI. The company is also noted for its high quality, growing position in the healthcare scheduling software industry, with excitement around its potential for further acquisitions. Overall, the experts have expressed confidence and high expectations for VHI's future performance and growth potential.

Consensus
positive
Valuation
fair value
WEAK BUY
VitalHub Corp.

Amazing job. Underlying metrics on profitability are incredible, but can it continue? If yes, will be a multi-compounder for years to come. As they keep delivering, so does confidence that they can keep doing so. Vast addressable market. Savvy management. 

You have to watch carefully that numbers back up the story. Safe to accumulate.

Healthcare
PARTIAL BUY
VitalHub Corp.
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

VHI’s EBITDA margin has improved in recent quarters to 26% in Q2-2024 compared to last year’s 23%. EBITDA Margins have improved gradually due to a business model with highly favourable operational leverage, where most of the growth flows straight to the bottom line due to the limited capex required. The recent acquisition of Strata Health marks VHI’s largest acquisition ever. We have comments on the recent acquisition here

VHI will fund the acquisition for a total up-front consideration of $32.3M through a combination of cash ($18.6M) and 1,480,726 shares. On the trailing twelve-month basis, Strata Health generated $12.7M in revenue and has an annual recurring revenue (ARR) of $12.3M, the deal is valued at 2.6x ARR. We think the deal is highly accretive to VHI as VHI itself is trading at around 10x ARR. We like the deal, we think VHI can continue to execute its acquisitive growth strategy in an efficient way going forward.
Unlock Premium - Try 5i Free  

Healthcare
BUY
VitalHub Corp.

Still loves it, one of his largest positions, high quality, growing. All-time high today. Benefitting from rate-hike sentiment. Healthcare scheduling software. Excitement around raising money to make acquisitions, which have yet to come to pass. Very good acquirers. Still reasonable at around 20x.

Healthcare
PAST TOP PICK
VitalHub Corp.
(A Top Pick Mar 12/24, Up 20%)*Note the short timeframe.

He has big expectations. Sitting on a pile of cash to make acquisitions. Thinks it will be a $10 stock in a year. Exceptionally good company.

Healthcare
TOP PICK
VitalHub Corp.

Margins are 22% and the company projects 40%. Trades at 18-19x PE. Will grow topline at 15-20% annually for the next 5 years as profits grow faster. Is the next Descartes.

(Analysts’ price target is $6.45)
Healthcare
BUY
VitalHub Corp.
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

2Q sales rose 38% to $13.1M; margins dipped to 81% from 83% due to an increase in lower margin service revenue. EBITDA nearly doubled to $1.9M. Net income was $0.72M from a loss last year. Cash was $22M. Results look good to us; Cormark raised its target price slightly. EPS is predicted to double in 2024, with slower growth following the next year. 
Unlock Premium - Try 5i Free

Healthcare
BUY ON WEAKNESS
VitalHub Corp.

Healthcare tech company.
Has owned on and off over the past few years.
Very strong management team.
Multiple is high given current share price.
Defensive software name.

Healthcare
Unspecified
VitalHub Corp.
It is a patient flow technology company combining health and technology. He has held it off and on in varying amounts over the years. Management has done a great job growing the business and producing recurring revenue. Although it is doing the right things he would like to see more profitability and a higher ROE.
Healthcare
BUY
VitalHub Corp.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Sales growth has restarted. Margins contracted slightly. Revenues increased by 36% from the same quarter a year prior. They overall missed their quarter but growth prospects still look pretty good. Unlock Premium - Try 5i Free

Healthcare
PARTIAL BUY
VitalHub Corp.
He got in very early at 15 cents. Their software help hospitals manage patients and increase efficiency. Very active in the UK. Management has built a company like this before and are doing it again now. Topline growth has been great, but he'd like to see more profit growth. The stock is a good trader around $3 where it has been stuck. This could be a take-out candidate one day, but nothing is imminent.
Healthcare
PARTIAL BUY
VitalHub Corp.
They are buying small healthcare tech companies. They have been executing the acquisition plan at a pretty good pace. Sometimes it gets lumped in with the more speculative healthcare tech companies. They have a lot of cash on the balance sheet. (Analysts’ price target is $4.77)
Healthcare
RISKY
VitalHub Corp.

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Competition in the space has increased. The valuation has reached above 6x sales. Valuation is more reasonable at 3x sales. The company also has small cap risk but sales growth has been strong. A 5+ years time horizon. Unlock Premium - Try 5i Free

Healthcare
WATCH
VitalHub Corp.
He kind of likes this business. The valuation is more reasonable than some others in the space. He is keeping his eye on it. They are in a good segment of the business.
Healthcare
COMMENT
VitalHub Corp.
He spoke with management about 2 weeks ago. 2020 is the year of great opportunity for them. They continue to win large contracts here and in the Middle East. He does not own it. (Analysts’ price target is $3.25)
Healthcare
COMMENT
VitalHub Corp.
Something happened to this on Jan. 6 (a 10-2 stock split), and it's up 1,100% this month. Hard to talk about this, technically. Do fundamental analysis. Maybe enter at $2.20. Reverse consolidations are usually not good.
Healthcare
Showing 1 to 15 of 18 entries

VitalHub Corp.(VHI-T) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 4

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 4

Stockchase rating for VitalHub Corp. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

VitalHub Corp.(VHI-T) Frequently Asked Questions

What is VitalHub Corp. stock symbol?

VitalHub Corp. is a Canadian stock, trading under the symbol VHI-T on the Toronto Stock Exchange (VHI-CT). It is usually referred to as TSX:VHI or VHI-T

Is VitalHub Corp. a buy or a sell?

In the last year, 4 stock analysts published opinions about VHI-T. 4 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for VitalHub Corp..

Is VitalHub Corp. a good investment or a top pick?

VitalHub Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for VitalHub Corp..

Why is VitalHub Corp. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is VitalHub Corp. worth watching?

4 stock analysts on Stockchase covered VitalHub Corp. In the last year. It is a trending stock that is worth watching.

What is VitalHub Corp. stock price?

On 2024-12-11, VitalHub Corp. (VHI-T) stock closed at a price of $11.64.